Dong-E-E-Jiao Co Ltd
SZSE:000423

Watchlist Manager
Dong-E-E-Jiao Co Ltd Logo
Dong-E-E-Jiao Co Ltd
SZSE:000423
Watchlist
Price: 63 CNY 0.1% Market Closed
Market Cap: 40.5B CNY
Have any thoughts about
Dong-E-E-Jiao Co Ltd?
Write Note

Relative Value

The Relative Value of one Dong-E-E-Jiao Co Ltd stock under the Base Case scenario is 68.03 CNY. Compared to the current market price of 63 CNY, Dong-E-E-Jiao Co Ltd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
68.03 CNY
Undervaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
52
vs Industry
20
Median 3Y
6.8
Median 5Y
6.8
Industry
2.5
Forward
7.1
vs History
71
vs Industry
17
Median 3Y
34.3
Median 5Y
33.6
Industry
21.8
Forward
27.8
vs History
23
vs Industry
24
Median 3Y
14.7
Median 5Y
14.5
Industry
16.1
vs History
20
vs Industry
22
Median 3Y
15.1
Median 5Y
14.4
Industry
23.8
vs History
9
vs Industry
24
Median 3Y
3.1
Median 5Y
2.5
Industry
2.1
vs History
50
vs Industry
24
Median 3Y
5.1
Median 5Y
5.4
Industry
2.7
Forward
5.7
vs History
63
vs Industry
28
Median 3Y
7.7
Median 5Y
8.4
Industry
5.2
vs History
65
vs Industry
18
Median 3Y
24.7
Median 5Y
23.8
Industry
13.5
Forward
18.4
vs History
65
vs Industry
22
Median 3Y
24.7
Median 5Y
23.8
Industry
16.8
Forward
20.4
vs History
25
vs Industry
29
Median 3Y
11
Median 5Y
10.9
Industry
15.2
vs History
20
vs Industry
24
Median 3Y
11.3
Median 5Y
10.9
Industry
19.3
vs History
9
vs Industry
16
Median 3Y
4.6
Median 5Y
2.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Dong-E-E-Jiao Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Dong-E-E-Jiao Co Ltd
SZSE:000423
40.6B CNY 7.2 26.7 20.6 20.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.2B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
350.6B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
252B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.4 10.5 15.9
P/S Multiple
Revenue Growth P/S to Growth
CN
Dong-E-E-Jiao Co Ltd
SZSE:000423
Average P/S: 382 942.6
7.2
64%
0.1
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
4 211 733
22%
194 879.4
US
Eli Lilly and Co
NYSE:LLY
18.5
109%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
29%
19.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.2
77%
0.1
US
Johnson & Johnson
NYSE:JNJ
4
13%
0.3
US
Merck & Co Inc
NYSE:MRK
4
20%
0.2
CH
Roche Holding AG
SIX:ROG
3.4
15%
0.2
UK
AstraZeneca PLC
LSE:AZN
4.1
35%
0.1
CH
Novartis AG
SIX:NOVN
3.8
17%
0.2
US
Pfizer Inc
NYSE:PFE
2.5
10%
0.3
P/E Multiple
Earnings Growth P/E to Growth
CN
Dong-E-E-Jiao Co Ltd
SZSE:000423
Average P/E: 31.7
26.7
77%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Dong-E-E-Jiao Co Ltd
SZSE:000423
Average EV/EBITDA: 415.6
20.6
98%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Dong-E-E-Jiao Co Ltd
SZSE:000423
Average EV/EBIT: 1 812.2
20.6
78%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top